Related Experiment Videos
Suppression of tumor growth in vivo by local and systemic 90K level increase
B Jallal1, J Powell, J Zachwieja
1Sugen, Inc., Redwood City, California 94063, USA.
Abstract:
Expression levels of the immunostimulatory 90K antigen in mammary carcinoma, glioblastoma, and other tumor-derived cell lines inversely correlate with their tumorigenicity in athymic mice. Engineered enhancement of 90K expression results in significant (> 80%) tumor growth inhibition, not by direct action on the tumor cell, but by stimulation of the residual cell-mediated immune defense of the nude mouse. Enhanced 90K level effects are both localized and systemic and involve induction of ICAM-1 and VCAM-1 in the tumor endothelium. The findings presented suggest a role for 90K as a molecular alarm signal for the body's cellular defense against pathogens, which in a subset of tumors is suppressed to allow cancer progression.
Insights
The 90K antigen, an immunostimulatory molecule, shows inverse correlation with tumor growth. Enhancing 90K expression inhibits tumor progression by boosting the immune system, not directly targeting cancer cells.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The 90K antigen is an immunostimulatory molecule.
- Tumorigenicity in certain cancers correlates inversely with 90K antigen expression levels.
- Tumor cells can suppress the body's immune defense mechanisms.
Purpose of the Study:
- To investigate the role of the 90K antigen in tumor progression.
- To determine if enhancing 90K expression can inhibit tumor growth.
- To elucidate the mechanism by which 90K affects tumor growth and the immune system.
Main Methods:
- Studied expression levels of the 90K antigen in mammary carcinoma, glioblastoma, and other tumor cell lines.
- Engineered cells to enhance 90K expression.
- Assessed tumor growth in athymic mice.
- Analyzed the effects of enhanced 90K expression on tumor endothelium, including ICAM-1 and VCAM-1 induction.
- Evaluated the impact on the host's cell-mediated immune defense.
Main Results:
- Inverse correlation observed between 90K antigen expression and tumorigenicity in athymic mice.
- Engineered enhancement of 90K expression led to significant tumor growth inhibition (>80%).
- Tumor growth inhibition was mediated by stimulation of the host's immune defense, not direct action on tumor cells.
- Enhanced 90K levels induced ICAM-1 and VCAM-1 in tumor endothelium, affecting both localized and systemic immunity.
Conclusions:
- The 90K antigen acts as a molecular alarm signal for cellular defense against pathogens.
- Tumor progression in a subset of cancers involves the suppression of 90K's immune-stimulating function.
- Targeting or enhancing 90K expression presents a potential therapeutic strategy for cancer treatment by leveraging the host's immune system.